MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Drug Safety
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

204 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
204 works in the cohort · of 4,299,418page 2 of 5

Labels cover 0 of 204 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 204 of 204 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Corticosteroid-Induced Osteoporosis
Jonathan D. Adachi, Alexandra Papaioannou
2001· review· en· Drug Safety· Medicine
machine prediction:candidate · noneconsensus · none
52
citations
affno abstractunlabeled
Risk Perception and Reasons for Noncompliance in Pharmacovigilance
Vincent Nichols, Isabelle Thériault-Dubé, Julie Touzin, Jean‐François Delisle, Denis Lebel, Jean‐François Bussières +2 more
2009· article· en· Drug Safety· Pharmacology, Toxicology and Pharmaceutics
machine prediction:candidate · noneconsensus · none
52
citations
affno abstractunlabeled
Hydroxyurea in the Treatment of HIV Infection
Julianna Lisziewicz, Andrea Foli, Mark A. Wainberg, Franco Lori
2003· review· en· Drug Safety· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
48
citations
affno abstractunlabeled
Fulfilling an Unmet Need in Psoriasis
Neil H. Shear
2006· review· en· Drug Safety· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
39
citations
affno abstractunlabeled
Quantifying Adverse Drug Events
Mahyar Etminan, Bruce Carleton, Paula A. Rochon
2004· review· en· Drug Safety· Pharmacology, Toxicology and Pharmaceutics
machine prediction:candidate · noneconsensus · none
27
citations
affno abstractunlabeled
Overview of Seizure-Inducing Potential of Doripenem
George G. Zhanel, Nzeera Ketter, Ethan Rubinstein, Ian R. Friedland, Rebecca Redman
2009· review· en· Drug Safety· Medicine
machine prediction:candidate · noneconsensus · none
26
citations
affno abstractunlabeled
Interaction Between Aspirin and ACE Inhibitors
Bahi Takkouche, Mahyar Etminan, Francisco Caama o, Paula A. Rochon
2002· review· en· Drug Safety· Medicine
machine prediction:candidate · noneconsensus · none
24
citations
affno abstractunlabeled
Improving Global Monitoring of Vaccine Safety
Megan Letourneau, George A. Wells, Wikke Walop, Philippe Duclos
2008· article· en· Drug Safety· Pharmacology, Toxicology and Pharmaceutics
machine prediction:candidate · noneconsensus · none
24
citations
← previousnext →

How this was built: Screen · Findings · About